BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3725829)

  • 1. Phencyclidine-induced wet-dog shakes observed in rats after withdrawal from reserpine treatment.
    Nabeshima T; Yamaguchi K; Yoshida S; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1986 May; 24(5):1275-9. PubMed ID: 3725829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phencyclidine-induced head-weaving and head-twitch through interaction with 5-HT1 and 5-HT2 receptors in reserpinized rats.
    Yamaguchi K; Nabeshima T; Ishikawa K; Yoshida S; Kameyama T
    Neuropharmacology; 1987 Oct; 26(10):1489-97. PubMed ID: 2446188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic involvement in phencyclidine-induced behaviors.
    Nabeshima T; Yamaguchi K; Hiramatsu M; Amano M; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1984 Sep; 21(3):401-8. PubMed ID: 6208563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.
    Adell A; Sarna GS; Hutson PH; Curzon G
    Br J Pharmacol; 1989 May; 97(1):206-12. PubMed ID: 2720308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors.
    Yamaguchi K; Nabeshima T; Kameyama T
    J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.
    Kuhn DM; Wolf WA; Youdim MB
    Br J Pharmacol; 1985 Jan; 84(1):121-9. PubMed ID: 2579697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appearance of wet dog shake behavior during cobalt experimental epilepsy in the rat and its suppression by reserpine.
    Colasanti BK; Kosa JE; Craig CR
    Psychopharmacologia; 1975 Oct; 44(1):33-6. PubMed ID: 1239031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.
    Gorzalka BB; Hill MN; Sun JC
    Eur J Pharmacol; 2005 May; 516(1):28-33. PubMed ID: 15913602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat.
    Yap CY; Taylor DA
    Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cessation of chronic nicotine administration enhances wet-dog shake responses to 5-HT2 receptor stimulation in rats.
    Suemaru K; Araki H; Kitamura Y; Yasuda K; Gomita Y
    Psychopharmacology (Berl); 2001 Dec; 159(1):38-41. PubMed ID: 11797067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lithium treatment on extracellular serotonin levels in the dorsal hippocampus and wet-dog shakes in the rat.
    Mørk A
    Eur Neuropsychopharmacol; 1998 Dec; 8(4):267-72. PubMed ID: 9928915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of morphine on 'wet-dog' shakes caused by cerebroventricular injection of serotonin.
    Drust EG; Sloviter RS; Connor JD
    Pharmacology; 1979; 18(6):299-305. PubMed ID: 573908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methysergide-induced precipitated withdrawal syndrome in phencyclidine-dependent rats.
    Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
    Neurosci Lett; 1986 Sep; 69(3):275-8. PubMed ID: 3763058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic activation of the spinal serotonergic system in the rat by phencyclidine in vitro.
    Ohno Y; Warnick JE
    J Pharmacol Exp Ther; 1989 Jul; 250(1):177-83. PubMed ID: 2746496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
    Fessler RG; Sturgeon RD; Meltzer HY
    Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phencyclidine-induced dopamine-dependent behaviors in chronic haloperidol-treated rats.
    Yamaguchi K; Nabeshima T; Amano M; Yoshida S; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1985 Nov; 23(5):803-9. PubMed ID: 4080767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of imipramine and lithium on wet-dog shakes mediated by the 5-HT2A receptor in ACTH-treated rats.
    Kitamura Y; Araki H; Suemaru K; Gomita Y
    Pharmacol Biochem Behav; 2002 May; 72(1-2):397-402. PubMed ID: 11900811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against the involvement of serotonergic mechanisms in wet dog shake behavior induced by carbachol chloride in rats.
    Turski L; Turski W; Czuczwar SJ; Kleinrok Z
    Psychopharmacology (Berl); 1981; 73(4):376-80. PubMed ID: 6454900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.